Weaponizing the Nipah Virus:  Rapidly Accelerating Strategic Risks  Inside the Chinese Communist Party System
Creators: name: Quay, Steven
name: Clarke, Ryan
name: Lin, Xiaoxu Sean
name: McCreight, Robert
name: Eads, LJ
name: Asher, David
name: Bomgaars, Will
Publisher: name: Zenodo
Year: 2024
Subjects: subject: Rna viruses
subject: Nipah virus
subject: SARS-CoV-2
subject: COVID-19
subject: Gain of function research
subject: Bioweapons
subject: Vaccines

description: This article brings together and summarizes the extraordinary efforts the Chinese government has undertaken over the past five years that continue in the present on a single human virus: the Nipah Virus. Despite not being a threat to public health in China, the natural properties of the Nipah Virus have many of the attributes that are desirable in a bioweapon. Even assuming defensive and dual use intentions, the level and intensity would be unprecedented without credible evidence that it was a threat to China itself.

The authors provide a comprehensive military, political, and scientific analysis that documents a deep research program on developing countermeasures to a Nipah virus, synthetic biology on the Nipah virus, and a network of companies and academic institutes in Asia within the umbrella of the CCP-driven effort. Section titles include:

·       Weaponized Zoonotic Pathogens and Other Biological Weapons: Core Elements of the CCP’s Standard Order of Battle

·       Civil-Military Fusion and National Security Law

·       Evidence CCP used COVID-19 for Strategic Opportunity

·       Overt CCP Strategic Maneuvers During the COVID-19 Outbreak

·       Frontline South China Sea: Strategic Testing Ground for Bioweapons Deployment?

·       Blurring the Line Between Civil and Military in the Maritime Domain

·       Inferring Strategic Intent from the CCP’s 2020 Actions

·       Bioweapons Converge with the Cybersecurity Domain

·       CCP’s ‘Three Warfares’ Strategy and Combined Arms Warfare

·       Gain of Function Research on Nipah Virus

·       August 2022 LayV Outbreak: PLA in Command, Anomalous Infection Patterns with Likely Human Experimentation

·       The Wuhan Institute of Virology: Track Record of Conducting Synthetic Biology Experiments with the Bangladesh strain of Nipah Virus from at least 2019 to 2023

·       The CCP is Actively Engaged in Additional Nipah Bangladesh Virus Vaccine Efforts Utilizing Military Technology

·       Some Chinese Work is Focused on the Less Lethal Nipah Malaysian Strain, But is Being Conducted in BSL2 Labs Under High-Risk Conditions

·       Joint Sino-Pakistani Scientific Teams Use Cutting Edge, Advanced Immunoinformatics Techniques to Create Vaccines for Langya Viruses

·       The Demonstrated Geospatial Distribution of Nipah Virus Indicates China is an Unlikely Location for a Natural Human Outbreak

·       The WIV and Shi Zhengli (At Least) Officially Acknowledged Clear Interest in the Nipah Virus in December 2019

·       The Langya Virus and the 2014 Mojiang Virus Isolate Tongguan1 Have Unusual Homologies, Consistent with Recombination (Either Naturally or in a Laboratory)

·       The PLA’s Academy of Military Medical Sciences Actively Patented Therapies for SARS-CoV-2, Ebola, Marburg, and Nipah Viruses

·       WuXi AppTech and WuXi Biologics: The Commercialization/Operationalization Arm of the CCP’s Next-Generation of High-Risk Nipah Research? A Direct Pathway into the United States?

·       WuXi AppTec Shareholding and Ownership Structure

·       Pairing Weaponized Pathogens (Like Nipah) with Nanoweapons

·       Emerging Nanotechnology and Biological Warfare Fusion: Evidence from the PLA and CCP-Run ‘Civilian’ Institutions

·       Combined Biological and Cyber Weapon Swarms: ‘Frontier Research’ Conducted at Shanghai Jiao Tong University and the State Grid Electric Power Research Institute

·       Hefei Institute of Physical Science (Chinese Academy of Sciences) Develops Nanorobot Capable of Conducting Biological Sieges

·       The Student Becomes the Master: The CCP’s Bioweapons and Nanoweapons Programs Are Now Domestically Self-Sufficient

·       The New Master Trains New Students: Current Status of the CCP-Led WIV-DESTO Bioweapons Program in Pakistan

·       What is the Chinese Academy of Medical Sciences? Like WIV, It Is Not a Civilian Operation

·       CCP’s ‘Lift and Drop’ Bioweapons Options for DESTO: GoF Research on SARS-CoV-2/Zika/MERS Viruses, Developing Purely Synthetic Viruses in the Lab

·       The Pakistan Army’s Use of Terrorist Groups Generates Bioweapons Down-Streaming Risks, especially with Lashkar-e-Taiba

·       The Full Investigation, Assessment, and Elimination of the joint WIV-DESTO Program Needs to be a Top International Priority

·       Existential Risks Escalating within the CCP System: Historically Unprecedented Threats Emerging